Skip to main content
. 2018 Apr 12;5(5):ofy077. doi: 10.1093/ofid/ofy077

Table 3.

Intervention

Intervention All Episodes (n = 103) PIV (n = 48) RSV (n = 33) MPV (n = 22)
Ribavirin+IVIGa, n (%) 39 (37.9) 3 (6.3) 20 (60.6) 16 (72.7)
IVIG, n (%) 24 (23.3) 19 (39.6) 3 (9.1) 2 (9.1)
None, n (%) 40 (38.8) 26 (54.2) 10 (30.3) 4 (18.2)

Abbreviations: IVIG, intravenous immunoglobulin; MPV, human metapneumovirus; PIV, parainfluenza virus; RSV, respiratory syncytial virus.

aOne patient additionally received palivizumab, 2 patients did not receive IVIG.